Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05355701
Title A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Pfizer

Advanced Solid Tumor


Binimetinib + PF-07799933


Cetuximab + PF-07799933

Age Groups: adult | child | senior
Covered Countries USA

Additional content available in CKB BOOST